Positron emission tomography is a unique technique that provides quantitative cross-sectional images of radiotracer concentrations in myocardium and affords non-invasive measurements of regional myocardial blood flow and metabolism. We hypothesize that exercise in patients with coronary artery disease (CAD) not only produces myocardial perfusion abnormalities but also metabolic derangements that can be detected noninvasively with PET and radiotracers of blood flow and metabolism.
Our aim i s to develop a superior technique for diagnosing the severity, location, and extent of exercise-induced ischemia. The positron-emitter Nitrogen-13 labeled ammonia will be used with PET to measure myocardial blood flow. Fluorine-18 labeled fluorodeoxyglucose (FDG), an analog of glucose, will be used to measure glucose metabolism, and N-13 labeled glutamate (GLU) will be used to assess the metabolism of glutamate. The metabolism of glucose and glutamate are both affected by ischemia. An important part of this proposal is to determine what the normal response of flow and metabolism of glucose and glutamate is to exercise in subjects without cardiac disease. Each subject/patient will have a baseline PET study with N-13 ammonia and either FDG or GLU prior to undergoing a supine exercise test. Repeat imaging with the same two isotopes will be performed sequentially with exercise testing, with the N-13 ammonia imaging being performed first. Observations by PET in CAD patients will be compared to those in age-matched normals to define abnormal responses. The duration of ischemia-induced metabolic abnormalities will be assessed. The PET data will also be correlated with the clinical status of the patient (e.g. severity of angina), ECG changes with exercise, quantitative arteriograms, and global and regional left ventricular function. It is anticipated that the proposed research will improve the detection of CAD and determination of the extent of disease, but more importantly will allow determination of the functional significance of coronary artery disease; e.g. the separation of critical from non-critical stenoses and assessment of the severity of stress-induced ischemia. Lastly, the proposed studies are likely to provide new insights into the pathophysiology of stress-induced ischemia.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL036232-02
Application #
3351024
Study Section
Diagnostic Radiology Study Section (RNM)
Project Start
1986-09-30
Project End
1991-09-29
Budget Start
1987-09-30
Budget End
1988-09-29
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of California Los Angeles
Department
Type
Organized Research Units
DUNS #
119132785
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Choi, Y; Huang, S C; Hawkins, R A et al. (1999) Quantification of myocardial blood flow using 13N-ammonia and PET: comparison of tracer models. J Nucl Med 40:1045-55
Krivokapich, J; Czernin, J; Schelbert, H R (1996) Dobutamine positron emission tomography: absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease. J Am Coll Cardiol 28:565-72
Chan, S Y; Kobashigawa, J; Stevenson, L W et al. (1994) Myocardial blood flow at rest and during pharmacological vasodilation in cardiac transplants during and after successful treatment of rejection. Circulation 90:204-12
Choi, Y; Huang, S C; Hawkins, R A et al. (1993) A refined method for quantification of myocardial oxygen consumption rate using mean transit time with carbon-11-acetate and dynamic PET. J Nucl Med 34:2038-43
Krivokapich, J; Huang, S C; Schelbert, H R (1993) Assessment of the effects of dobutamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. Am J Cardiol 71:1351-6
Chan, S Y; Brunken, R C; Czernin, J et al. (1992) Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 20:979-85
Krivokapich, J; Stevenson, L W; Kobashigawa, J et al. (1991) Quantification of absolute myocardial perfusion at rest and during exercise with positron emission tomography after human cardiac transplantation. J Am Coll Cardiol 18:512-7
Krivokapich, J; Huang, S C; Ratib, O et al. (1991) Noninvasive detection of functionally significant coronary artery stenoses with exercise and positron emission tomography. Am Heart J 122:202-11
Krivokapich, J; Barrio, J R; Huang, S C et al. (1990) Dynamic positron tomographic imaging with nitrogen-13 glutamate in patients with coronary artery disease: comparison with nitrogen-13 ammonia and fluorine-18 fluorodeoxyglucose imaging. J Am Coll Cardiol 16:1158-67
Krivokapich, J; Smith, G T; Huang, S C et al. (1989) 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 80:1328-37

Showing the most recent 10 out of 11 publications